Last edition
News about Global Pharma
Hengrui Pharma has signed agreements with GSK to develop up to 12 innovative medicines across respiratory, immunology and inflammation, and oncology. It includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPD and additional 11 programmes to be developed by Hengrui Pharma and optioned by GSK.
Global Pharma | 28/07/2025 | By Mrinmoy Dey | 312
Elpis Biopharmaceuticals has signed an MoU with the National Cancer Centre Singapore. The collaboration focuses on advancing clinically validated armoured CAR technologies into first-in-human trials in Singapore and accelerating translational research from bench-to-bedside.
Global Pharma | 28/07/2025 | By Mrinmoy Dey | 275
AstraZeneca's Imfinzi Granted Priority Review by FDA for Early-Stage Gastric and GEJ Cancers
The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) and granted Priority Review for the treatment of patients with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric and gastroesophageal junction (GEJ) cancers.
Global Pharma | 28/07/2025 | By Dineshwori | 175
Pfizer and BioNTech's Updated COVID-19 Vaccine Secures EMA Nod, Awaits Final EU Approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Pfizer- BioNTech's LP.8.1-adapted monovalent COVID-19 vaccine in the European Union.
Global Pharma | 28/07/2025 | By Dineshwori | 234
Matchpoint, Novartis Partner to Develop Oral Inhibitors for Multiple Inflammatory Diseases
Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialise oral covalent inhibitors for multiple inflammatory diseases.
Global Pharma | 28/07/2025 | By Dineshwori | 186
India's Pharma Exports Surge 92 Percent in Six Years: Anupriya Patel
Driven by various government schemes, India’s drug and pharmaceutical exports have risen from INR 1,28,028 crore in FY2018-19 to INR 2,45,962 crore in FY2024-25.
Global Pharma | 26/07/2025 | By Dineshwori | 339
India-UK FTA: A New Era for India's Pharma Industry
India currently exports pharmaceutical goods worth approximately USD 914 million (around INR 7,600 crore) annually to the UK. With the new FTA in place, this figure is expected to surge significantly, particularly for generic medicines, bulk drugs, and biosimilars.
Global Pharma | 26/07/2025 | By Darshana | 243
Laurus Labs Posts Strong Q1 FY26 Results With 31 Percent Revenue Growth
Laurus Labs has reported strong financial results for the first quarter of FY26, with consolidated revenues reaching INR 1,570 crore—a 31 percent year-on-year increase.
Global Pharma | 26/07/2025 | By Dineshwori | 1375
Mankind Pharma Expands into Sri Lanka With New Subsidiary
Mankind Pharma has incorporated a wholly owned subsidiary, Mankind Pharma Lanka (Private) Ltd., in Sri Lanka as part of its international expansion strategy.
Global Pharma | 26/07/2025 | By Dineshwori | 331
Lilly Completes Acquisition of Verve Therapeutics
Eli Lilly and Company has completed its acquisition of Verve Therapeutics, a Boston-based clinical-stage firm developing genetic medicines for cardiovascular disease.
Global Pharma | 26/07/2025 | By Mrinmoy Dey | 443
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy